WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
maximize
Machine translation
1. (WO2007016950) COMPOSITION FOR REDUCING THE RISK OF ALCOHOL INDUCED NEURODEGENERATIVE DISEASE
Note: Text based on automatic Optical Character Recognition processes. Please use the PDF version for legal matters

CLAIMS

1. Food composition, or dietary supplementation for reducing alcohol induced rise of neurodegenerative disease including late-onset Alzheimer's disease by moderating an alcohol degradation process in respect to ethanol metabolism within the human body, including the following substances in physiologically relevant amount:

niacin (Vitamin B3),
dextrose,
Vitamin C,
L-glutamine,
cysteine,
riboflavin,
succinic acid, and/or fumaric acid,
coenzyme QlO.

2. Food composition or dietary supplementation according to claim 1, wherein a dose of same has a weight of about 13.8g, said dose being configured in a manner which allows same to be consumed within a restaurant or a bar prior to the consumption of alcohol.

3. Food composition or dietary supplementation according to claim 1 or 2, wherein a dose of same includes a dextrose fraction of about 75.2 mass%.

4. Food composition or dietary supplementation according to at least one of claims 1 to 3, wherein a dose of same includes a Vitamin C fraction of about 7.5 mass%.

5. Food composition or dietary supplementation according to at least one of claims 1 to 4, wherein a dose of same includes a L-glutamine fraction of about 11.28 mass%.

6. Food composition or dietary supplementation according to at least one of claims 1 to 5, wherein a dose of same includes a cysteine fraction of about 3.76 mass%.

7. Food composition or dietary supplementation according to at least one of claims 1 to 6, wherein a dose of same includes a riboflavin fraction of about 0.3 mass%.

8. Food composition or dietary supplementation according to at least one of claims 1 to 7, wherein a dose of same includes a succinic acid fraction of about 0.752 mass%.

9. Food composition or dietary supplementation according to at least one of claims 1 to 8, wherein a dose of same includes a fumaric acid fraction of about 0.752 mass%.

10. Food composition or dietary supplementation according to at least one of claims 1 to 9, wherein a dose of same includes a coenzyme fraction of about 0.451 mass%.

11. Food composition or dietary supplementation according to at least one of claims 1 to 10, wherein same is in the form of tablets.

12. Food composition or dietary supplementation according to at least one of claims 1 to 10, wherein a dose of same includes a plurality of small tablets or capsules.

13. Food composition or dietary supplementation according to at least one of claims 1 to 10, wherein said tablets or capsules are contained in a dosage receptacle.

14. Food composition or dietary supplementation according to at least one of claims 1 to 10, wherein said composition is of a sugar-cube type form.

15. Food composition or dietary supplementation according to at least one of claims 1 to 10, wherein same is in the form of cryopowder.

16. Food composition or dietary supplementation according to at least one of claims 1 to 10, wherein same is in the form of a small drink unit.

17. Food composition or dietary supplementation according to at least one of claims 1 to 10, wherein same is in the form of a sirup.

18. Food composition, or dietary supplementation for reducing alcohol induced rise of neurodegenerative disease including late-onset Alzheimer's disease including niacin for affecting an alcohol degrading process in particular in respect to ethanol metabolism within the human body, and substances, in particular substances mentioned above, providing the following effects within the human body:
Reducing ethanol metabolism by slowing down the process of ethanol oxidation into acetaldehyde, to prevent accumulation of acetaldehyde in the first place;
Stimulating the activity of ALDH and avoiding any blockade of its enzymatic activity;
Speeding up the reaction from acetaldehyde to acetic acid and further decomposition in the citrate cycle;
- Improving the levels of those anti-oxidants of the alcohol consumer which specially protect against toxic effects of acetaldehyde.